Previous 10 | Next 10 |
2023-03-29 08:17:00 ET Despite being one of the world's largest, most steadily growing businesses, Amazon 's (NASDAQ: AMZN) stock fell by around 40% in the last 12 months, leaving investors looking for alternatives to buy for growth. Nonetheless, Wall Street analysts predict that Am...
2023-03-22 05:30:00 ET Here's one of the many great truths about investing. You don't need an enormous amount of cash to start -- or even continue -- on your path to wealth. With just about any amount, you can get in on some exciting stories or add to your current positions. Right now, ...
2023-03-19 08:27:52 ET Summary InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with significant revenue growth, strong margins, and no deb...
InMode Updates It Does Not Hold Cash Deposits at SVB PR Newswire YOKNEAM, Israel , March 13, 2023 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that that it does not hold cash deposi...
2023-03-08 11:23:12 ET Summary With a 44% margin of safety, InMode Ltd. is a growth company trading at value prices. InMode's full-year 2022 results and earnings call did little to quell investor frustrations and concerns over future growth. Has the market concluded INMD stock...
InMode to Present In-Person at the Barclays Global Health Conference PR Newswire YOKNEAM, Israel , March 2, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) , a leading global provider of innovative medical technologies, today announced that Yair Malca , C...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in under-the-radar growth stocks can be a great way to gain exposure to companies that have the potential to outperform the market. By investing in these stocks, investors can capitalize on opportunities that may no...
InMode Ltd. ( NASDAQ: INMD ) dropped for the second straight session on Friday as the Israel-based MedTech company received the first Hold rating on Wall Street after Needham downgraded it from Buy, citing its Q4 2022 results. According to Seeking Alpha’s Wall Street ratings, I...
Sometimes the best opportunities are found in the laggards. Take medical technology (or medtech) stocks, for example. As a group, medtech stocks haven't performed well over the last year. However, their long-term potential should be great. Two underperforming medtech stocks especially stand o...
Image source: The Motley Fool. InMode (NASDAQ: INMD) Q4 2022 Earnings Call Feb 14, 2023 , 8:30 a.m. ET Operator Continue reading For further details see: InMode (INMD) Q4 2022 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...